Literature DB >> 19966925

An essential role of ubiquitination in Cbl-mediated negative regulation of the Src-family kinase Fyn.

Navin Rao1, Amiya K Ghosh, Patrice Douillard, Christopher E Andoniou, Pengcheng Zhou, Hamid Band.   

Abstract

The Cbl family of ubiquitin ligases function as negative regulators of activated receptor tyrosine kinases by facilitating their ubiquitination and subsequent lysosomal targeting. Here, we have investigated the role of Cbl ubiquitin ligase activity in the negative regulation of a non-receptor tyrosine kinase, the Src-family kinase Fyn. Using primary embryonic fibroblasts from Cbl(+/+) and Cbl(-/-) mice, we demonstrate that endogenous Cbl mediates the ubiquitination of Fyn and dictates the rate of Fyn turnover. By analyzing CHO-TS20 cells with a temperature-sensitive ubiquitin activating enzyme, we demonstrate that intact cellular ubiquitin machinery is required for Cbl-induced degradation of Fyn. Analyses of Cbl mutants, with mutations in or near the RING finger domain, in 293T cells revealed that the ubiquitin ligase activity of Cbl is essential for Cbl-induced degradation of Fyn by the proteasome pathway. Finally, use of a SRE-luciferase reporter demonstrated that Cbl-dependent negative regulation of Fyn function requires the region of Cbl that mediates the ubiquitin ligase activity. Given the conservation of structure between various Src-family kinases and the ability of Cbl to interact with multiple members of this family, Cbl-dependent ubiquitination could serve a general role to negatively regulate activated Src-family kinases.

Entities:  

Year:  2002        PMID: 19966925      PMCID: PMC2788922          DOI: 10.1002/1615-4061(200205)2:1/2<29::AID-SITA29>3.0.CO;2-7

Source DB:  PubMed          Journal:  Signal Transduct        ISSN: 1615-4053


  54 in total

Review 1.  The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction.

Authors:  M L Lupher; N Rao; M J Eck; H Band
Journal:  Immunol Today       Date:  1999-08

2.  Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416). Effect of introducing a high affinity intramolecular SH2 ligand.

Authors:  M Porter; T Schindler; J Kuriyan; W T Miller
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

3.  The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.

Authors:  C E Andoniou; N L Lill; C B Thien; M L Lupher; S Ota; D D Bowtell; R M Scaife; W Y Langdon; H Band
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 4.  The measurement of ubiquitin and ubiquitinated proteins.

Authors:  E G Mimnaugh; P Bonvini; L Neckers
Journal:  Electrophoresis       Date:  1999-02       Impact factor: 3.535

5.  Crystal structure of the Src family tyrosine kinase Hck.

Authors:  F Sicheri; I Moarefi; J Kuriyan
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

6.  The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70.

Authors:  M L Lupher; Z Songyang; S E Shoelson; L C Cantley; H Band
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

7.  Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin.

Authors:  K Alexandropoulos; D Baltimore
Journal:  Genes Dev       Date:  1996-06-01       Impact factor: 11.361

8.  c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption.

Authors:  S Tanaka; M Amling; L Neff; A Peyman; E Uhlmann; J B Levy; R Baron
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

9.  Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323.

Authors:  M L Lupher; N Rao; N L Lill; C E Andoniou; S Miyake; E A Clark; B Druker; H Band
Journal:  J Biol Chem       Date:  1998-12-25       Impact factor: 5.157

10.  Constitutive activation of Src family kinases in mouse embryos that lack Csk.

Authors:  S Nada; T Yagi; H Takeda; T Tokunaga; H Nakagawa; Y Ikawa; M Okada; S Aizawa
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

View more
  7 in total

1.  Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins.

Authors:  Scott Nadeau; Wei An; Nick Palermo; Dan Feng; Gulzar Ahmad; Lin Dong; Gloria E O Borgstahl; Amarnath Natarajan; Mayumi Naramura; Vimla Band; Hamid Band
Journal:  Biochem Anal Biochem       Date:  2012-07-30

2.  Cdk5 targets active Src for ubiquitin-dependent degradation by phosphorylating Src(S75).

Authors:  Q Pan; F Qiao; C Gao; B Norman; L Optican; Peggy S Zelenka
Journal:  Cell Mol Life Sci       Date:  2011-03-27       Impact factor: 9.261

3.  A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling.

Authors:  Navin Rao; Steven Nguyen; Karen Ngo; Wai-Ping Fung-Leung
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 4.  Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.

Authors:  Bhopal Mohapatra; Gulzar Ahmad; Scott Nadeau; Neha Zutshi; Wei An; Sarah Scheffe; Lin Dong; Dan Feng; Benjamin Goetz; Priyanka Arya; Tameka A Bailey; Nicholas Palermo; Gloria E O Borgstahl; Amarnath Natarajan; Srikumar M Raja; Mayumi Naramura; Vimla Band; Hamid Band
Journal:  Biochim Biophys Acta       Date:  2012-10-17

5.  A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.

Authors:  Benjamin Goetz; Wei An; Bhopal Mohapatra; Neha Zutshi; Fany Iseka; Matthew D Storck; Jane Meza; Yuri Sheinin; Vimla Band; Hamid Band
Journal:  Oncotarget       Date:  2016-08-09

6.  Alzheimer's disease: insights from a network medicine perspective.

Authors:  Federica Conte; Paola Paci
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

7.  Depletion of Csk preferentially reduces the protein level of LynA in a Cbl-dependent manner in cancer cells.

Authors:  Takahisa Kuga; Yuka Yamane; Soujirou Hayashi; Masanari Taniguchi; Naoto Yamaguchi; Nobuyuki Yamagishi
Journal:  Sci Rep       Date:  2020-05-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.